Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability and food effect study of OPC-131461 in healthy adults
jRCT2071210093Phase 1Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of OPC-131461 in heart failure (HF) (4 cohorts), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoints: Primary pharmacokinetic endpoints - relative bioavailability and Primary pharmacokinetic endpoints - food effect. Started Jan 2022; status: completed.
02
Drugs
OPC-131461
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on jRCT2071210093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210093.